NO943739D0 - Vaksiner inneholdende ikke-ioniske overflate-aktive vaksiner - Google Patents
Vaksiner inneholdende ikke-ioniske overflate-aktive vaksinerInfo
- Publication number
- NO943739D0 NO943739D0 NO943739A NO943739A NO943739D0 NO 943739 D0 NO943739 D0 NO 943739D0 NO 943739 A NO943739 A NO 943739A NO 943739 A NO943739 A NO 943739A NO 943739 D0 NO943739 D0 NO 943739D0
- Authority
- NO
- Norway
- Prior art keywords
- pct
- vaccines
- vesicles
- sec
- nonionic surfactant
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 239000002736 nonionic surfactant Substances 0.000 title abstract 2
- QHZLMUACJMDIAE-UHFFFAOYSA-N 1-monopalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 150000002314 glycerols Chemical class 0.000 abstract 1
- 239000000568 immunological adjuvant Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000002563 ionic surfactant Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/45—Toxoplasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929207731A GB9207731D0 (en) | 1992-04-07 | 1992-04-07 | Improvements in or relating to vaccines |
| PCT/GB1993/000716 WO1993019781A1 (en) | 1992-04-07 | 1993-04-06 | Vaccines containing non-ionic surfactant vesicles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO943739L NO943739L (no) | 1994-10-05 |
| NO943739D0 true NO943739D0 (no) | 1994-10-05 |
Family
ID=10713695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO943739A NO943739D0 (no) | 1992-04-07 | 1994-10-05 | Vaksiner inneholdende ikke-ioniske overflate-aktive vaksiner |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5679355A (no) |
| EP (1) | EP0634937B1 (no) |
| JP (1) | JP2690620B2 (no) |
| KR (1) | KR950700758A (no) |
| CN (1) | CN1085449A (no) |
| AT (1) | ATE158185T1 (no) |
| AU (1) | AU3899793A (no) |
| CA (1) | CA2132547C (no) |
| DE (1) | DE69314020T2 (no) |
| FI (1) | FI944676A (no) |
| GB (1) | GB9207731D0 (no) |
| HU (1) | HUT69935A (no) |
| NO (1) | NO943739D0 (no) |
| NZ (1) | NZ251402A (no) |
| WO (1) | WO1993019781A1 (no) |
| ZA (1) | ZA932491B (no) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995003035A1 (en) * | 1993-07-23 | 1995-02-02 | Massachusetts Institute Of Technology | Polymerized liposomes with enhanced stability for oral delivery |
| US5919466A (en) * | 1993-10-01 | 1999-07-06 | Gerbu Biotechnik Gmbh | Method for improving the yield of immunoantibodies in the vaccination of animals and humans |
| GB9320597D0 (en) * | 1993-10-06 | 1993-11-24 | Proteus Molecular Design | Improvements in and realting to vaccines |
| AU680996B2 (en) * | 1993-12-17 | 1997-08-14 | Novavax, Inc. | Method of transmitting a biologically active material to a cell |
| US5688506A (en) * | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
| GB9515868D0 (en) * | 1995-08-02 | 1995-10-04 | Proteus Molecular Design | Therapeutic method |
| GB9600471D0 (en) * | 1996-01-10 | 1996-03-13 | Univ London Pharmacy | Drug delivery system |
| BR9909915A (pt) * | 1998-04-09 | 2000-12-26 | Smithkline Beecham Biolog | Composições adjuvantes |
| US6494865B1 (en) * | 1999-10-14 | 2002-12-17 | Becton Dickinson And Company | Intradermal delivery device including a needle assembly |
| FR2802422B1 (fr) * | 1999-12-21 | 2002-08-09 | Capsulis | Structures mixtes resultant de l'incorporation d'une macromolecule biologique, en particulier d'adn, dans une phase structuree d'amphiphiles et vesicules obtenues a partir de ces structures |
| GB9930591D0 (en) * | 1999-12-23 | 2000-02-16 | Univ London | Component for vaccine |
| FI112825B (fi) * | 2001-07-11 | 2004-01-15 | Antti Nissinen | Menetelmä alkoholinkulutuksen osoittamiseksi, menetelmässä käytettäviä välineitä sekä niiden valmistus |
| CA2489919A1 (en) * | 2002-07-03 | 2004-01-15 | Aphton Corporation | Liposomal vaccine |
| WO2004045583A1 (ja) * | 2002-11-15 | 2004-06-03 | Nipro Corporation | リポソーム |
| FR2850872A1 (fr) * | 2003-02-12 | 2004-08-13 | Ethypharm Sa | Composition vaccinale destinee a induire une reponse immunitaire contre le virus responsable du sida |
| CN100509072C (zh) | 2003-08-28 | 2009-07-08 | 贝克顿·迪金森公司 | 皮内注射装置 |
| JP2009509970A (ja) * | 2005-09-22 | 2009-03-12 | プロサイ インコーポレイテッド | 酵母突然変異体において産生されるグリコシル化ポリペプチドおよびその使用方法 |
| CA2735724C (en) | 2008-06-19 | 2018-07-24 | Variation Biotechnologies Inc. | Compositions and methods for treating influenza |
| EP2644227B1 (en) | 2008-07-30 | 2016-12-28 | Ecole Polytechnique Fédérale de Lausanne | Apparatus for optimized stimulation of a neurological target |
| WO2010055421A1 (en) | 2008-11-12 | 2010-05-20 | Aleva Neurotherapeutics, S.A. | Microfabricated neurostimulation device |
| US9907746B2 (en) | 2009-07-06 | 2018-03-06 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
| MX2012000372A (es) | 2009-07-06 | 2012-02-28 | Variation Biotechnologies Inc | Metodos para preparar vesiculas y formulaciones producidas a partir de las mismas. |
| WO2011067297A1 (en) | 2009-12-01 | 2011-06-09 | ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE | Microfabricated neurostimulation device and methods of making and using the same |
| SG184395A1 (en) | 2010-04-01 | 2012-11-29 | Ecole Polytech | Device for interacting with neurological tissue and methods of making and using the same |
| US9238796B2 (en) | 2010-06-04 | 2016-01-19 | Toagosei Co. Ltd. | Cell growth-promoting peptide and use thereof |
| JP6119030B2 (ja) | 2010-07-06 | 2017-04-26 | ヴァリエーション バイオテクノロジーズ インコーポレイテッド | インフルエンザを治療するための組成物及び方法 |
| WO2012093706A1 (ja) * | 2011-01-07 | 2012-07-12 | 東亞合成株式会社 | 抗疎水性ペプチド抗体を得るための抗原調製方法 |
| WO2012093732A1 (ja) * | 2011-01-07 | 2012-07-12 | セイコーエプソン株式会社 | アミロイド前駆体タンパク質のシグナルペプチドに対する抗体 |
| EP2663327A4 (en) | 2011-01-13 | 2015-12-02 | Variation Biotechnologies Inc | COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS |
| US20130323280A1 (en) * | 2011-01-13 | 2013-12-05 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
| AU2013208693B2 (en) | 2012-01-12 | 2017-12-07 | Variation Biotechnologies Inc. | Compositions and methods for treating viral infections |
| CA2894467A1 (en) * | 2012-01-27 | 2013-08-01 | Variation Biotechnologies Inc. | Methods for preparing thermostable compositions comprising a lipid component and thermolabile therapeutic agents |
| JP6066222B2 (ja) | 2012-05-28 | 2017-01-25 | 東亞合成株式会社 | 抗菌ペプチド及びその利用 |
| US9480727B2 (en) | 2012-10-18 | 2016-11-01 | Toagosei Co. Ltd. | Synthetic peptide for inhibiting expression of type 2 TNF receptor and use thereof |
| EP3476430B1 (en) | 2014-05-16 | 2020-07-01 | Aleva Neurotherapeutics SA | Device for interacting with neurological tissue |
| US11311718B2 (en) | 2014-05-16 | 2022-04-26 | Aleva Neurotherapeutics Sa | Device for interacting with neurological tissue and methods of making and using the same |
| US9474894B2 (en) | 2014-08-27 | 2016-10-25 | Aleva Neurotherapeutics | Deep brain stimulation lead |
| US9403011B2 (en) | 2014-08-27 | 2016-08-02 | Aleva Neurotherapeutics | Leadless neurostimulator |
| CN109069824B (zh) | 2016-02-02 | 2022-09-16 | 阿莱瓦神经治疗股份有限公司 | 使用深部脑刺激治疗自身免疫疾病 |
| GB201612108D0 (en) * | 2016-07-12 | 2016-08-24 | Univ Strathclyde | Preperation of non-ionic surfactant vesicles and variants |
| US10702692B2 (en) | 2018-03-02 | 2020-07-07 | Aleva Neurotherapeutics | Neurostimulation device |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2408387A2 (fr) * | 1975-06-30 | 1979-06-08 | Oreal | Compositions a base de dispersions aqueuses de spherules lipidiques |
| FR2571963B1 (fr) * | 1984-10-24 | 1987-07-10 | Oreal | Composition a usage cosmetique ou pharmaceutique contenant des niosomes et au moins un polyamide hydrosoluble et procede de preparation de cette composition. |
| SE8405493D0 (sv) * | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| FR2597346B1 (fr) * | 1986-04-22 | 1989-08-18 | Oreal | Procede pour faciliter la formation de niosomes en dispersion dans une phase aqueuse et pour ameliorer leur stabilite et leur taux d'encapsulation, et dispersions correspondantes. |
| ATE71292T1 (de) * | 1987-03-13 | 1992-01-15 | Micro Vesicular Systems | Lipidversikel aus grenzflaechenaktiven stoffen und sterolen. |
| US4855090A (en) * | 1987-03-13 | 1989-08-08 | Micro-Pak, Inc. | Method of producing high aqueous volume multilamellar vesicles |
| GB8713240D0 (en) * | 1987-06-05 | 1987-07-08 | Proteus Biotech Ltd | Hormones |
| LU87449A1 (fr) * | 1989-02-09 | 1990-09-19 | Oreal | Procede de fabrication de mousses utilisables dans les domaines cosmetique et pharmaceutique et mousses obtenues par ce procede |
| IT1238343B (it) * | 1989-10-16 | 1993-07-13 | Cesalpino Andrea Fond | Procedimento per la preparazione di vaccini capaci di generare non solo la risposta immune dei linfociti t helper,ma anche un'efficace risposta di linfociti t citotossici,e vaccini con queste caratteristiche |
| BR9205819A (pt) * | 1991-03-28 | 1994-06-07 | Micro Vesicular Systems | Emulsoes de água em óleo contendo vesículas de lipídio |
-
1992
- 1992-04-07 GB GB929207731A patent/GB9207731D0/en active Pending
-
1993
- 1993-04-06 CA CA002132547A patent/CA2132547C/en not_active Expired - Fee Related
- 1993-04-06 WO PCT/GB1993/000716 patent/WO1993019781A1/en active IP Right Grant
- 1993-04-06 EP EP93908000A patent/EP0634937B1/en not_active Expired - Lifetime
- 1993-04-06 HU HU9402904A patent/HUT69935A/hu unknown
- 1993-04-06 AU AU38997/93A patent/AU3899793A/en not_active Abandoned
- 1993-04-06 AT AT93908000T patent/ATE158185T1/de active
- 1993-04-06 DE DE69314020T patent/DE69314020T2/de not_active Expired - Fee Related
- 1993-04-06 NZ NZ251402A patent/NZ251402A/en unknown
- 1993-04-06 JP JP5517269A patent/JP2690620B2/ja not_active Expired - Fee Related
- 1993-04-06 US US08/302,915 patent/US5679355A/en not_active Expired - Fee Related
- 1993-04-07 CN CN93105224A patent/CN1085449A/zh active Pending
- 1993-04-07 ZA ZA932491A patent/ZA932491B/xx unknown
-
1994
- 1994-10-05 NO NO943739A patent/NO943739D0/no unknown
- 1994-10-06 FI FI944676A patent/FI944676A/fi not_active Application Discontinuation
- 1994-10-07 KR KR1019940703545A patent/KR950700758A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT69935A (en) | 1995-09-28 |
| EP0634937B1 (en) | 1997-09-17 |
| KR950700758A (ko) | 1995-02-20 |
| JP2690620B2 (ja) | 1997-12-10 |
| JPH07505389A (ja) | 1995-06-15 |
| NO943739L (no) | 1994-10-05 |
| FI944676A0 (fi) | 1994-10-06 |
| ZA932491B (en) | 1993-11-02 |
| ATE158185T1 (de) | 1997-10-15 |
| AU3899793A (en) | 1993-11-08 |
| NZ251402A (en) | 1996-10-28 |
| CA2132547C (en) | 2000-06-06 |
| DE69314020D1 (de) | 1997-10-23 |
| DE69314020T2 (de) | 1998-08-06 |
| US5679355A (en) | 1997-10-21 |
| EP0634937A1 (en) | 1995-01-25 |
| CA2132547A1 (en) | 1993-10-14 |
| FI944676A (fi) | 1994-10-06 |
| CN1085449A (zh) | 1994-04-20 |
| WO1993019781A1 (en) | 1993-10-14 |
| GB9207731D0 (en) | 1992-05-27 |
| HU9402904D0 (en) | 1995-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO943739D0 (no) | Vaksiner inneholdende ikke-ioniske overflate-aktive vaksiner | |
| FI955667A0 (fi) | Adjuvantteja RS-viruksen vastaisia rokotteita varten | |
| DK0760649T3 (da) | Præparater af fluticason-propionat | |
| DE69231837D1 (de) | Antigen praesentierende ms2-huelle | |
| DK0682528T3 (da) | Lægemiddelpræparat til topisk administration af antigener og/eller vacciner til pattedyr via en slimhindemembran | |
| ATE350057T1 (de) | Impfstoffzusammesetzung | |
| ATE153071T1 (de) | Neue proteinhaltige partikeln | |
| DK0489153T3 (da) | Vaccinepræparater indeholdende liposomer | |
| DK0588578T3 (da) | Immunogener | |
| DK1267924T3 (da) | Immunterapeutiske metoder og sammensætninger | |
| GEP20053446B (en) | Adjuvant Combination Formulations | |
| ATE185073T1 (de) | Impfstoff zubereitungen | |
| NO175846C (no) | Fremgangsmåte for å oppnå et immunogen | |
| DE69322960T2 (de) | Empfängnisverhütender impfstoff | |
| CO5070581A1 (es) | Vacunas | |
| MX9710523A (es) | Vacunas contra hepatitis c. |